Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Cash from Investing Activities data on file, last reported at -$4.8 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 14.34% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.4 million (up 2.86% YoY) and the FY2025 annual result came in at -$32.2 million, down 5.98% from the prior year.
• Cash from Investing Activities retreated to -$4.8 million in Q1 2026 per GRDN's latest filing, from -$4.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$1.1 million in Q4 2023, with the low at -$13.1 million in Q2 2024.
• Average Cash from Investing Activities over 4 years is -$6.9 million, with a median of -$6.1 million recorded in 2024.
• Year-over-year, Cash from Investing Activities sank 477.51% in 2024 and climbed 28.89% in 2025.
• Guardian Pharmacy Services' Cash from Investing Activities stood at -$1.1 million in 2023, then slumped by 477.51% to -$6.6 million in 2024, then rose by 28.89% to -$4.7 million in 2025, then fell by 0.85% to -$4.8 million in 2026.
• Business Quant data shows GRDN's Cash from Investing Activities at -$4.8 million in Q1 2026, -$4.7 million in Q4 2025, and -$9.0 million in Q3 2025.